Logo image of STG

SUNLANDS TECHNOLOGY- SP ADR (STG) Stock Fundamental Analysis

NYSE:STG - New York Stock Exchange, Inc. - US86740P2074 - ADR - Currency: USD

5.935  +0.17 (+3.04%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to STG. STG was compared to 72 industry peers in the Diversified Consumer Services industry. While STG has a great profitability rating, there are some minor concerns on its financial health. STG has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year STG was profitable.
Of the past 5 years STG 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: STG reported negative operating cash flow in multiple years.
STG Yearly Net Income VS EBIT VS OCF VS FCFSTG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

STG has a better Return On Assets (14.33%) than 93.06% of its industry peers.
With an excellent Return On Equity value of 50.58%, STG belongs to the best of the industry, outperforming 94.44% of the companies in the same industry.
STG has a better Return On Invested Capital (15.91%) than 94.44% of its industry peers.
The Average Return On Invested Capital over the past 3 years for STG is significantly above the industry average of 10.91%.
The last Return On Invested Capital (15.91%) for STG is well below the 3 year average (39.95%), which needs to be investigated, but indicates that STG had better years and this may not be a problem.
Industry RankSector Rank
ROA 14.33%
ROE 50.58%
ROIC 15.91%
ROA(3y)24.89%
ROA(5y)13.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)39.95%
ROIC(5y)N/A
STG Yearly ROA, ROE, ROICSTG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

STG's Profit Margin of 15.56% is amongst the best of the industry. STG outperforms 90.28% of its industry peers.
In the last couple of years the Profit Margin of STG has grown nicely.
The Operating Margin of STG (13.60%) is better than 75.00% of its industry peers.
In the last couple of years the Operating Margin of STG has grown nicely.
STG has a better Gross Margin (83.98%) than 95.83% of its industry peers.
STG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.6%
PM (TTM) 15.56%
GM 83.98%
OM growth 3Y48.68%
OM growth 5YN/A
PM growth 3Y25.3%
PM growth 5YN/A
GM growth 3Y-0.39%
GM growth 5Y0.5%
STG Yearly Profit, Operating, Gross MarginsSTG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), STG is creating value.
STG has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, STG has less shares outstanding
Compared to 1 year ago, STG has an improved debt to assets ratio.
STG Yearly Shares OutstandingSTG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
STG Yearly Total Debt VS Total AssetsSTG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.40, we must say that STG is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.40, STG perfoms like the industry average, outperforming 40.28% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that STG is not too dependend on debt financing.
STG has a Debt to Equity ratio of 0.06. This is in the better half of the industry: STG outperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 0.4
ROIC/WACC1.89
WACC8.44%
STG Yearly LT Debt VS Equity VS FCFSTG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

2.3 Liquidity

STG has a Current Ratio of 1.10. This is a normal value and indicates that STG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.10, STG is in line with its industry, outperforming 43.06% of the companies in the same industry.
STG has a Quick Ratio of 1.10. This is a normal value and indicates that STG is financially healthy and should not expect problems in meeting its short term obligations.
STG has a Quick ratio (1.10) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
STG Yearly Current Assets VS Current LiabilitesSTG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1

3. Growth

3.1 Past

STG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.43%.
The Earnings Per Share has been growing by 15.31% on average over the past years. This is quite good.
Looking at the last year, STG shows a decrease in Revenue. The Revenue has decreased by -7.65% in the last year.
The Revenue has been decreasing by -1.93% on average over the past years.
EPS 1Y (TTM)-46.43%
EPS 3Y15.31%
EPS 5YN/A
EPS Q2Q%-32.81%
Revenue 1Y (TTM)-7.65%
Revenue growth 3Y-7.42%
Revenue growth 5Y-1.93%
Sales Q2Q%-7.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
STG Yearly Revenue VS EstimatesSTG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
STG Yearly EPS VS EstimatesSTG Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 -20 -40 -60

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 1.91 indicates a rather cheap valuation of STG.
Based on the Price/Earnings ratio, STG is valued cheaper than 98.61% of the companies in the same industry.
When comparing the Price/Earnings ratio of STG to the average of the S&P500 Index (26.52), we can say STG is valued rather cheaply.
Industry RankSector Rank
PE 1.91
Fwd PE N/A
STG Price Earnings VS Forward Price EarningsSTG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, STG is valued cheaply inside the industry as 97.22% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.04
STG Per share dataSTG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The excellent profitability rating of STG may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for STG!.
Industry RankSector Rank
Dividend Yield N/A

SUNLANDS TECHNOLOGY- SP ADR

NYSE:STG (6/6/2025, 8:04:01 PM)

5.935

+0.17 (+3.04%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)05-22 2025-05-22/bmo
Earnings (Next)N/A N/A
Inst Owners0.08%
Inst Owner Change-36.98%
Ins Owners13.65%
Ins Owner ChangeN/A
Market Cap80.28M
Analysts42.5
Price TargetN/A
Short Float %0.2%
Short Ratio6.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.31
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.91
Fwd PE N/A
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB 0.96
EV/EBITDA 2.04
EPS(TTM)3.11
EY52.4%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS20.12
BVpS6.19
TBVpS6.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 14.33%
ROE 50.58%
ROCE 20.14%
ROIC 15.91%
ROICexc 15.91%
ROICexgc 15.92%
OM 13.6%
PM (TTM) 15.56%
GM 83.98%
FCFM N/A
ROA(3y)24.89%
ROA(5y)13.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)39.95%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)50.57%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y48.68%
OM growth 5YN/A
PM growth 3Y25.3%
PM growth 5YN/A
GM growth 3Y-0.39%
GM growth 5Y0.5%
F-ScoreN/A
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA 0.12
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 0.4
F-ScoreN/A
WACC8.44%
ROIC/WACC1.89
Cap/Depr(3y)9.59%
Cap/Depr(5y)27.86%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.47%
Profit Quality(3y)26.37%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.43%
EPS 3Y15.31%
EPS 5YN/A
EPS Q2Q%-32.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.65%
Revenue growth 3Y-7.42%
Revenue growth 5Y-1.93%
Sales Q2Q%-7.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.14%
EBIT growth 3Y37.65%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y45.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.01%
OCF growth 3YN/A
OCF growth 5YN/A